ArticleCell reports2021

The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants.

Efi Makdasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.